Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1461]

ASCO 2013: Bevacizumab extends survival for relapsed and advanced cervical cancer

ASCO 2013: Bevacizumab extends survival for relapsed and advanced cervical cancer

ASCO 2013: Indian study finds biennial cervical cancer screening with vinegar reduces mortality

ASCO 2013: Indian study finds biennial cervical cancer screening with vinegar reduces mortality

ASCO 2013: Maintenance therapy with the multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

ASCO 2013: Maintenance therapy with the multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

ASCO 2013: Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections

ASCO 2013: Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections

Genomic re-classification of uterine cancer could affect treatment

Genomic re-classification of uterine cancer could affect treatment

US researchers unveil womb cancer and acute leukaemia genomes

US researchers unveil womb cancer and acute leukaemia genomes

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

ESTRO 2013: Two landmark studies report on success of using image-guided brachytherapy to treat cervical cancer

ESTRO 2013: Two landmark studies report on success of using image-guided brachytherapy to treat cervical cancer

Endometriosis treatments lower ovarian cancer risk

Endometriosis treatments lower ovarian cancer risk

AACR 2013: AKT inhibitor AZD5363 well tolerated, yielded partial response in patients with advanced solid tumours

AACR 2013: AKT inhibitor AZD5363 well tolerated, yielded partial response in patients with advanced solid tumours

More from ecancer